Stay updated with breaking news from Roivant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.
Immunovant (NASDAQ:IMVT – Get Free Report) and Solid Biosciences (NASDAQ:SLDB – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, profitability, risk, dividends, earnings and analyst recommendations. Analyst Ratings This is a summary of current ratings […]
Eric Venker, President & COO of Roivant Sciences Ltd (NASDAQ:ROIV), executed a sale of 96,950 shares in the company on February 9, 2024, according to a recent SEC Filing.
Presenter SpeechYatin Suneja Okay. Good afternoon, everyone. Yatin Suneja from Guggenheim. Welcome to our 6th Annual Biotechnology Conference. Our next presenting company is Roivant. From the company,...
Solid Biosciences (NASDAQ:SLDB – Get Free Report) and Immunovant (NASDAQ:IMVT – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability. Profitability This table compares Solid Biosciences and Immunovant’s net […]